Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Bipolar disorder, also known as manic depression, is a mental disorder that could lead to periods of depression and elevated mood. The treatment of bipolar disorder includes psychotherapy as well as medications such as mood stabilizers and antipsychotics.
Rise in prevalence of bipolar disorder, high unmet medical needs, technological advancement and government initiatives are the key factors accelerating the growth of the bipolar disorder therapeutics market. Increase in investment in research and development and collaboration activities between companies for product development are the other factors likely to propel the bipolar disorder therapeutics market. Additionally, the rise in awareness about the disorder has led to increased understanding among the public. This has led to a rise in the number of individuals seeking medical attention for the treatment of the disorder. Also, strategic alliances formed between vendors help in increased penetration of the drugs in the market and increase market share. However, stringent regulations act as a major restraint of the bipolar disorder therapeutics market. North America dominates the global bipolar disorder therapeutics market due to new product innovation, increased awareness among people about bipolar disease, and rise in prevalence of bipolar disorders.
The report details the trend, potential and market size of Biopolar Disorder Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Biopolar Disorder Therapeuticsmarket, defines the market attractiveness level of Biopolar Disorder Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Biopolar Disorder Therapeutics industry, describes the types of Biopolar Disorder Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Biopolar Disorder Therapeutics market and the development prospects and opportunities of Biopolar Disorder Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Biopolar Disorder Therapeutics market in Chapter 13.
By Player:
Eli Lilly
Allergan
AstraZeneca
GlaxoSmithKline
Janssen Pharmaceuticals
By Type:
Mood Stabilizers
Antipsychotic Drugs
Antidepressant Drugs
Others
By End-User:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Biopolar Disorder Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Biopolar Disorder Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Biopolar Disorder Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Biopolar Disorder Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Biopolar Disorder Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Biopolar Disorder Therapeutics Consumption (2017-2022)
-
7.2 United States Biopolar Disorder Therapeutics Consumption (2017-2022)
-
7.3 Europe Biopolar Disorder Therapeutics Consumption (2017-2022)
-
7.4 China Biopolar Disorder Therapeutics Consumption (2017-2022)
-
7.5 Japan Biopolar Disorder Therapeutics Consumption (2017-2022)
-
7.6 India Biopolar Disorder Therapeutics Consumption (2017-2022)
-
7.7 South Korea Biopolar Disorder Therapeutics Consumption (2017-2022)
8 Region and Country-wise Biopolar Disorder Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Biopolar Disorder Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Biopolar Disorder Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Biopolar Disorder Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Biopolar Disorder Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Biopolar Disorder Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Biopolar Disorder Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Biopolar Disorder Therapeutics Consumption Forecast (2022-2028)
9 Global Biopolar Disorder Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Biopolar Disorder Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Mood Stabilizers Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Antipsychotic Drugs Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Antidepressant Drugs Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Biopolar Disorder Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
10 Global Biopolar Disorder Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Biopolar Disorder Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Mood Stabilizers Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Antipsychotic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Antidepressant Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Biopolar Disorder Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
11 Global Biopolar Disorder Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Biopolar Disorder Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Biopolar Disorder Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Biopolar Disorder Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Biopolar Disorder Therapeutics Market Competitive Analysis
-
14.1 Eli Lilly
-
14.1.1 Eli Lilly Company Details
-
14.1.2 Eli Lilly Biopolar Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Eli Lilly Biopolar Disorder Therapeutics Product and Service
-
14.2 Allergan
-
14.2.1 Allergan Company Details
-
14.2.2 Allergan Biopolar Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Allergan Biopolar Disorder Therapeutics Product and Service
-
14.3 AstraZeneca
-
14.3.1 AstraZeneca Company Details
-
14.3.2 AstraZeneca Biopolar Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 AstraZeneca Biopolar Disorder Therapeutics Product and Service
-
14.4 GlaxoSmithKline
-
14.4.1 GlaxoSmithKline Company Details
-
14.4.2 GlaxoSmithKline Biopolar Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 GlaxoSmithKline Biopolar Disorder Therapeutics Product and Service
-
14.5 Janssen Pharmaceuticals
-
14.5.1 Janssen Pharmaceuticals Company Details
-
14.5.2 Janssen Pharmaceuticals Biopolar Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Janssen Pharmaceuticals Biopolar Disorder Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Biopolar Disorder Therapeutics
-
Figure Biopolar Disorder Therapeutics Picture
-
Table Global Biopolar Disorder Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Biopolar Disorder Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Biopolar Disorder Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Biopolar Disorder Therapeutics Consumption by Country (2017-2022)
-
Figure United States Biopolar Disorder Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Biopolar Disorder Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Biopolar Disorder Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Biopolar Disorder Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Biopolar Disorder Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Biopolar Disorder Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Biopolar Disorder Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Biopolar Disorder Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Biopolar Disorder Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Biopolar Disorder Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Biopolar Disorder Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Biopolar Disorder Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Biopolar Disorder Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mood Stabilizers Consumption and Growth Rate (2017-2022)
-
Figure Global Antipsychotic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Antidepressant Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Mood Stabilizers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antipsychotic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antidepressant Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Biopolar Disorder Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Biopolar Disorder Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Biopolar Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Biopolar Disorder Therapeutics Product and Service
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Biopolar Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Biopolar Disorder Therapeutics Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Biopolar Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Biopolar Disorder Therapeutics Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Biopolar Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Biopolar Disorder Therapeutics Product and Service
-
Table Janssen Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Janssen Pharmaceuticals Biopolar Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Pharmaceuticals Biopolar Disorder Therapeutics Product and Service
-
